Clofibrate, a lipid lowering agent inhibits both cholesterol and triglyceride synthesis by:
Inhibiting HMG CoA reductase
Binding to bile acids and preventing its reabsorption
Inhibiting VLDL production
Activating lipoprotein lipase, resulting in VLDL degradation